Circulating tetrahydrobiopterin as a novel biomarker for abdominal aortic aneurysm

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 307, Issue 11, 2014, Pages H1559-H1564

  Siu, Kin Lung ^a   Cai, Hua ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Abdominal aortic aneurysm; Biomarker; eNOS; Folic acid; Tetrahydrobiopterin

Indexed keywords

ANGIOTENSIN II; FOLIC ACID; TETRAHYDROBIOPTERIN; ANTIANEMIC AGENT; APOLIPOPROTEIN E; BIOLOGICAL MARKER; BIOPTERIN; PHENYLALANINE; SAPROPTERIN; VASOCONSTRICTOR AGENT;

ABDOMINAL AORTA ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); HYPERPHENYLALANINEMIA; KNOCKOUT MOUSE; MOUSE; MURINE MODEL; NONHUMAN; PROTEIN BLOOD LEVEL; TETRAHYDROBIOPTERIN BLOOD LEVEL; TETRAHYDROBIOPTERIN TISSUE LEVEL; TIME; TISSUE LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; AORTIC ANEURYSM, ABDOMINAL; BLOOD; CHEMICALLY INDUCED; GENETICS; MALE;

ANGIOTENSIN II; ANIMALS; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; BIOMARKERS; BIOPTERIN; FOLIC ACID; HEMATINICS; MALE; MICE; MICE, KNOCKOUT; PHENYLALANINE; VASOCONSTRICTOR AGENTS;

EID: 84913558509     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00444.2014     Document Type: Article

References (34)

1. Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM. Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol24: 445–450, 2004.
2. Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation117: 1883–1889, 2008.
3. Centers for Disease Control and Prevention. About Compressed Mortality, 1999–2010. CDC WONDER Series 20, No. 2P, 2013 (Online). http://wonder.cdc.gov/cmf-icd10.html [25 Feb 2014].
4. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA102: 9056–9061, 2005.
5. Dalainas I, Nano G, Casana R, Tealdi Dg D. Mid-term results after endovascular repair of abdominal aortic aneurysms: a four-year experience. Eur J Vasc Endovasc Surg27: 319–323, 2004.
6. Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest105: 1605–1612, 2000.
7. Dubick MA, Keen CL, DiSilvestro RA, Eskelson CD, Ireton J, Hunter GC. Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease. Proc Soc Exp Biol Med220: 39–45, 1999.
8. Eugster T, Huber A, Obeid T, Schwegler I, Gurke L, Stierli P. Aminoterminal propeptide of type III procollagen and matrix metallopro-teinases-2 and -9 failed to serve as serum markers for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg29: 378–382, 2005.
9. Fillinger M. Who should we operate on and how do we decide: predicting rupture and survival in patients with aortic aneurysm. Semin Vasc Surg20: 121–127, 2007.
10. Gao L, Siu KL, Chalupsky K, Nguyen A, Chen P, Weintraub NL, Galis Z, Cai H. Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension59: 158–166, 2011.
11. Gavrila D, Li WG, McCormick ML, Thomas M, Daugherty A, Cassis LA, Miller FJ, Jr., Oberley LW, Dellsperger KC, Weintraub NL. Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol25: 1671–1677, 2005.
12. Hong H, Yang Y, Liu B, Cai W. Imaging of abdominal aortic aneurysm: the present and the future. Curr Vasc Pharmacol8: 808–819, 2010.
13. Glimaker H, Holmberg L, Elvin A, Nybacka O, Almgren B, Bjorck CG, Eriksson I. Natural history of patients with abdominal aortic aneu-rysm. Eur J Vasc Surg5: 125–130, 1991.
14. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE, Powell JT. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation103: 2260–2265, 2001.
15. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest111: 1201–1209, 2003.
16. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation103: 1282–1288, 2001.
17. Lindholt JS, Heickendorff L, Henneberg EW, Fasting H. Serum-elastin-peptides as a predictor of expansion of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg14: 12–16, 1997.
18. Lindholt JS, Heickendorff L, Vammen S, Fasting H, Henneberg EW. Five-year results of elastin and collagen markers as predictive tools in the management of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg21: 235–240, 2001.
19. Lindholt JS, Jorgensen B, Klitgaard NA, Henneberg EW. Systemic levels of cotinine and elastase, but not pulmonary function, are associated with the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg26: 418–422, 2003.
20. Lindholt JS, Vammen S, Fasting H, Henneberg EW, Heickendorff L. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg20: 281–285, 2000.
21. Marin ML, Hollier LH, Ellozy SH, Spielvogel D, Mitty H, Griepp R, Lookstein RA, Carroccio A, Morrissey NJ, Teodorescu VJ, Jacobs TS, Minor ME, Sheahan CM, Chae K, Oak J, Cha A. Endovascular stent graft repair of abdominal and thoracic aortic aneurysms: a ten-year experience with 817 patients. Ann Surg238: 586–593; discussion 593– 595, 2003.
22. Nakamura M, Tachieda R, Niinuma H, Ohira A, Endoh S, Hiramori K, Makita S. Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Angiology51: 385–392, 2000.
23. Oak JH, Cai H. Attenuation of angiotensin II signaling recouples eNOS and inhibits nonendothelial NOX activity in diabetic mice. Diabetes56: 118–126, 2007.
24. Ozaki M, Kawashima S, Yamashita T, Hirase T, Namiki M, Inoue N, Hirata K, Yasui H, Sakurai H, Yoshida Y, Masada M, Yokoyama M. Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice. J Clin Invest110: 331–340, 2002.
25. Porkert M, Sher S, Reddy U, Cheema F, Niessner C, Kolm P, Jones DP, Hooper C, Taylor WR, Harrison D, Quyyumi AA. Tetrahydrobi-opterin: a novel antihypertensive therapy. J Hum Hypertens22: 401–407, 2008.
26. Powell JT, Muller BR, Greenhalgh RM. Acute phase proteins in patients with abdominal aortic aneurysms. J Cardiovasc Surg (Torino)28: 528–530, 1987.
27. Satta J, Haukipuro K, Kairaluoma MI, Juvonen T. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms. J Vasc Surg25: 909–915, 1997.
28. Siu KL, Miao XN, Cai H. Recoupling of eNOS with folic acid prevents abdominal aortic aneurysm formation in angiotensin II-infused apolipo-protein E null mice. PLoS One9: e88899, 2014.
29. Thomas M, Gavrila D, McCormick ML, Miller FJ, Jr., Daugherty A, Cassis LA, Dellsperger KC, Weintraub NL. Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation114: 404–413, 2006.
30. Treska V, Topolcan O, Pecen L. Cytokines as plasma markers of abdominal aortic aneurysm. Clin Chem Lab Med38: 1161–1164, 2000.
31. Wever RM, van Dam T, van Rijn HJ, de Groot F, Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun237: 340–344, 1997.
32. Xia Y, Tsai AL, Berka V, Zweier JL. Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tet-rahydrobiopterin regulatory process. J Biol Chem273: 25804-25808, 1998.
33. Xiong W, Mactaggart J, Knispel R, Worth J, Zhu Z, Li Y, Sun Y, Baxter BT, Johanning J. Inhibition of reactive oxygen species attenuates aneurysm formation in a murine model. Atherosclerosis202: 128-134, 2009.
34. Youn JY, Gao L, Cai H. The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Dia-betologia55: 2069-2079, 2012.